XOLAIR Safety Study Continues to 2012 Despite Increased Rate of Occurrence of Heart Problems, Onder

XOLAIR Safety Study Continues to 2012 Despite Increased Rate of Occurrence of Heart Problems, Onder Law Firm Offers Free XOLAIR Case Review The FDA is reviewing preliminary safety information on XOLAIR allergic asthma medication. Problems with XOLAIR have been linked to heart attack and stroke. The Onder Law Firm is offering a free case review to those or families of those who may have experienced serious health problems after taking XOLAIR. St. Louis, MO (Vocus) November 14, 2009 -- The FDA is evaluating interim safety findings from Genen
Contributor
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations